Santalahti P, Hemminki E, Aro A R, Helenius H, Ryynänen M
Health Services Research Unit, National Research and Development Centre for Welfare and Health, University of Turku, Finland.
Fetal Diagn Ther. 1999 Mar-Apr;14(2):71-9. doi: 10.1159/000020893.
The study examined how prenatal screening tests are presented to women, factors associated with women's participation in screening, their experience of decision-making and intentions concerning pregnancy termination, and hospital data on rates of selective terminations.
Questionnaires were given to pregnant women visiting maternity centres in two Finnish towns in which serum screening was offered (n = 1,035) and in one town where midtrimester ultrasound screening was offered (n = 497). Response rates to the questionnaires were 88 and 85%, respectively. Other questionnaires asking about selective terminations following detected fetal disorders were sent in 1993 to all public hospitals with obstetrics or gynaecology departments (response rate 100%).
The serum screening test had usually been offered to women as a free choice, but for 22% of them it was presented as a routine procedure. Most women (92%) underwent serum screening and most (86%) found the decision to participate or not easy. In almost every aspect of presentation and participation studied, serum and ultrasound screening differed from each other. 85% of respondents to ultrasound screening answered that it was offered as a routine procedure. Close acquaintance with a person with congenital disability was negatively associated with participation in serum screening and with the intention to terminate pregnancy in case of a detected disability. 27% of women in the serum screening survey and 22% in the ultrasound survey declared that they would have declined pregnancy termination if a fetal disorder had been detected. However, according to the hospitals' data, only 13% of pregnancies with a serious fetal disorder detected were continued.
All prenatal screening tests, including ultrasound examinations, require an adequate process of informed consent. Because the aim of such tests is to detect fetal malformations and syndromes, health care professionals should discuss the implications with women before they decide. Because acquaintance with a disabled person was found to associate with participation in screening and with intentions about selective termination, women's perceptions of lives of the disabled should receive more attention in future studies.
本研究调查了产前筛查测试是如何向女性介绍的,与女性参与筛查相关的因素、她们的决策体验以及关于终止妊娠的意图,以及医院关于选择性终止妊娠率的数据。
对前往芬兰两个提供血清筛查的城镇的产妇中心就诊的孕妇(n = 1035)以及一个提供孕中期超声筛查的城镇的孕妇(n = 497)进行问卷调查。问卷的回复率分别为88%和85%。1993年,向所有设有妇产科的公立医院发放了其他关于检测到胎儿疾病后选择性终止妊娠的问卷(回复率100%)。
血清筛查测试通常作为一种自由选择提供给女性,但其中22%的女性将其视为常规程序。大多数女性(92%)接受了血清筛查,大多数(86%)发现决定是否参与并不容易。在所研究的介绍和参与的几乎每个方面,血清筛查和超声筛查都有所不同。接受超声筛查的受访者中有85%回答说这是作为常规程序提供的。与先天性残疾患者密切相识与参与血清筛查以及在检测到残疾时终止妊娠的意图呈负相关。血清筛查调查中有27%的女性和超声调查中有22%的女性表示,如果检测到胎儿疾病,她们会拒绝终止妊娠。然而,根据医院的数据,在检测到严重胎儿疾病的妊娠中,只有13%得以继续。
所有产前筛查测试,包括超声检查,都需要一个充分的知情同意过程。由于此类测试的目的是检测胎儿畸形和综合征,医疗保健专业人员应在女性做出决定之前与她们讨论其影响。由于发现与残疾人相识与参与筛查以及选择性终止妊娠的意图有关,在未来的研究中应更多地关注女性对残疾人生活的看法。